Minocin For Injection

— THERAPEUTIC CATEGORIES —
  • Acne
  • Bacterial infections
  • Protozoal infections

Minocin For Injection Generic Name & Formulations

General Description

Minocycline 100mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains magnesium sulfate heptahydrate.

Pharmacological Class

Tetracycline antibiotic.

See Also

How Supplied

Caps—60; Single-use vials—1, 10

Manufacturer

Minocin For Injection Indications

Indications

Adjunct in severe acne.

Minocin For Injection Dosage and Administration

Adult

Give by IV infusion over 60 mins. Initially 200mg once, then 100mg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children

≤8yrs: not recommended. Give by IV infusion over 60 mins. >8yrs: Initially 4mg/kg once, then 2mg/kg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Minocin For Injection Contraindications

Not Applicable

Minocin For Injection Boxed Warnings

Not Applicable

Minocin For Injection Warnings/Precautions

Warnings/Precautions

Monitor blood, renal, and hepatic function periodically. Discontinue if skin erythema, DRESS syndrome, or superinfection develops. Overweight women. History of intracranial hypertension. Monitor for visual disturbances. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Avoid sun or UV light. IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy, nursing mothers: not recommended.

Minocin For Injection Pharmacokinetics

See Literature

Minocin For Injection Interactions

Interactions

Avoid concomitant penicillins, isotretinoin. Fatal renal toxicity with concomitant methoxyflurane. Caution with other hepatotoxic drugs. May need to reduce concomitant anticoagulant dose. Absorption reduced by antacids containing aluminum, calcium, magnesium and iron. May antagonize oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

Minocin For Injection Adverse Reactions

Adverse Reactions

Dizziness, GI upset, pruritus, increased BUN; teeth discoloration, delayed skeletal development, intracranial hypertension, C.difficile-associated diarrhea, photosensitivity, hepatotoxicity, renal toxicity, skin/hypersensitivity reactions (may be severe), lupus-like syndrome, serum sickness-like syndrome. IV: magnesium intoxication, inj site reactions.

Minocin For Injection Clinical Trials

See Literature

Minocin For Injection Note

Not Applicable

Minocin For Injection Patient Counseling

See Literature

Minocin For Injection Generic Name & Formulations

General Description

Minocycline 100mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains magnesium sulfate heptahydrate.

Pharmacological Class

Tetracycline antibiotic.

See Also

How Supplied

Caps—60; Single-use vials—1, 10

Manufacturer

Minocin For Injection Indications

Indications

Tetracycline-susceptible infections including respiratory, genitourinary, rickettsial, trachoma. Alternative for selected infections when penicillin is contraindicated. Anthrax due to B. anthracis.

Minocin For Injection Dosage and Administration

Adult

Give by IV infusion over 60 mins. Initially 200mg once, then 100mg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children

≤8yrs: not recommended. Give by IV infusion over 60 mins. >8yrs: Initially 4mg/kg once, then 2mg/kg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Minocin For Injection Contraindications

Not Applicable

Minocin For Injection Boxed Warnings

Not Applicable

Minocin For Injection Warnings/Precautions

Warnings/Precautions

Monitor blood, renal, and hepatic function periodically. Discontinue if skin erythema, DRESS syndrome, or superinfection develops. Overweight women. History of intracranial hypertension. Monitor for visual disturbances. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Avoid sun or UV light. IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy, nursing mothers: not recommended.

Minocin For Injection Pharmacokinetics

See Literature

Minocin For Injection Interactions

Interactions

Avoid concomitant penicillins, isotretinoin. Fatal renal toxicity with concomitant methoxyflurane. Caution with other hepatotoxic drugs. May need to reduce concomitant anticoagulant dose. Absorption reduced by antacids containing aluminum, calcium, magnesium and iron. May antagonize oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

Minocin For Injection Adverse Reactions

Adverse Reactions

Dizziness, GI upset, pruritus, increased BUN; teeth discoloration, delayed skeletal development, intracranial hypertension, C.difficile-associated diarrhea, photosensitivity, hepatotoxicity, renal toxicity, skin/hypersensitivity reactions (may be severe), lupus-like syndrome, serum sickness-like syndrome. IV: magnesium intoxication, inj site reactions.

Minocin For Injection Clinical Trials

See Literature

Minocin For Injection Note

Not Applicable

Minocin For Injection Patient Counseling

See Literature

Minocin For Injection Generic Name & Formulations

General Description

Minocycline 100mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains magnesium sulfate heptahydrate.

Pharmacological Class

Tetracycline antibiotic.

See Also

How Supplied

Caps—60; Single-use vials—1, 10

Manufacturer

Minocin For Injection Indications

Indications

Adjunct in acute intestinal amebiasis.

Minocin For Injection Dosage and Administration

Adult

Give by IV infusion over 60 mins. Initially 200mg once, then 100mg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Children

≤8yrs: not recommended. Give by IV infusion over 60 mins. >8yrs: Initially 4mg/kg once, then 2mg/kg every 12hrs; max 400mg daily. Renal impairment (CrCl <80mL/min): max 200mg/day.

Minocin For Injection Contraindications

Not Applicable

Minocin For Injection Boxed Warnings

Not Applicable

Minocin For Injection Warnings/Precautions

Warnings/Precautions

Monitor blood, renal, and hepatic function periodically. Discontinue if skin erythema, DRESS syndrome, or superinfection develops. Overweight women. History of intracranial hypertension. Monitor for visual disturbances. Renal impairment; monitor BUN and creatinine. Hepatic impairment. Avoid sun or UV light. IV: monitor magnesium levels in renal impairment; and monitor closely in patients with heart block or myocardial damage. Pregnancy, nursing mothers: not recommended.

Minocin For Injection Pharmacokinetics

See Literature

Minocin For Injection Interactions

Interactions

Avoid concomitant penicillins, isotretinoin. Fatal renal toxicity with concomitant methoxyflurane. Caution with other hepatotoxic drugs. May need to reduce concomitant anticoagulant dose. Absorption reduced by antacids containing aluminum, calcium, magnesium and iron. May antagonize oral contraceptives. Concomitant ergots or derivatives; increased risk of ergotism. May interfere with fluorescence test. IV (contains magnesium): avoid concomitant CNS depressants, neuromuscular blockers, cardiac glycosides.

Minocin For Injection Adverse Reactions

Adverse Reactions

Dizziness, GI upset, pruritus, increased BUN; teeth discoloration, delayed skeletal development, intracranial hypertension, C.difficile-associated diarrhea, photosensitivity, hepatotoxicity, renal toxicity, skin/hypersensitivity reactions (may be severe), lupus-like syndrome, serum sickness-like syndrome. IV: magnesium intoxication, inj site reactions.

Minocin For Injection Clinical Trials

See Literature

Minocin For Injection Note

Not Applicable

Minocin For Injection Patient Counseling

See Literature